ANDA 81277, held by Teva Pharms USA. Leucovorin Calcium.
As of Nov 16, 2026, ANDA 81277 (Leucovorin Calcium), held by Teva Pharms USA, was first approved by FDA on Sep 28, 1993, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 28, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Leucovorin CalciumEQ 100MG BASE/VIAL · injectable;injection | Leucovorin Calcium | Discontinued |
| Apr 29, 2013 | Supplement 20Labeling · Standard review | Approved | None posted |
| Dec 16, 1998 | Supplement 6Labeling | Approved | None posted |
| Apr 28, 1998 | Supplement 5Labeling | Approved | None posted |
| Nov 10, 1997 | Supplement 3Labeling | Approved | None posted |
| Oct 30, 1997 | Supplement 4Manufacturing | Approved | None posted |
| May 20, 1996 | Supplement 2Labeling | Approved | None posted |
| Jul 5, 1994 | Supplement 1Manufacturing | Approved | None posted |
| Sep 28, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters